LAS-38096

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameLAS-38096

Drug Alias NameLAS-38096

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAdenosine A2b receptor antagonists

TargetsAdenosine A2b receptor

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlmirall Sas

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAlmirall Sas

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A